This segment of the research not only underscores the significance of immune cells in the pathological processes of DM but also provides additional empirical evidence for IER3 as a potential biomarker, opening new avenues for the diagnosis, treatment, and prognostic evaluation of DM. This evidence concerns the gene IER3 and diabetes mellitus.